Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
-- Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- SHANGHAI, June 17, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX:...
Quantum Metal Recovery Inc. Responds to Besra Gold's ASX Announcement, Initiates Legal Proceedings in Ontario
PENANG, Malaysia, June 6, 2025 /PRNewswire/ -- Quantum Metal Recovery Inc. (QMRI), the largest shareholder of Besra Gold Inc. (Besra), has issued a formal response to Besra's 22 May 2025 ASX announcement titled "Market Update: Clarification of...